0001309653-23-000002.txt : 20230111 0001309653-23-000002.hdr.sgml : 20230111 20230111161219 ACCESSION NUMBER: 0001309653-23-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230109 FILED AS OF DATE: 20230111 DATE AS OF CHANGE: 20230111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: AZAB MOHAMMAD CENTRAL INDEX KEY: 0001309653 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33650 FILM NUMBER: 23523706 MAIL ADDRESS: STREET 1: C/O SUPERGEN, INC. STREET 2: 4140 DUBLIN BLVD., SUITE 200 CITY: DUBLIN STATE: CA ZIP: 94568 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LISATA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0000320017 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] IRS NUMBER: 222343568 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 110 ALLEN ROAD STREET 2: SECOND FLOOR CITY: BASKING RIDGE STATE: NJ ZIP: 07920 BUSINESS PHONE: 908-229-2590 MAIL ADDRESS: STREET 1: 110 ALLEN ROAD STREET 2: SECOND FLOOR CITY: BASKING RIDGE STATE: NJ ZIP: 07920 FORMER COMPANY: FORMER CONFORMED NAME: CALADRIUS BIOSCIENCES, INC. DATE OF NAME CHANGE: 20170808 FORMER COMPANY: FORMER CONFORMED NAME: Caladrius Biosciences, Inc. DATE OF NAME CHANGE: 20150608 FORMER COMPANY: FORMER CONFORMED NAME: NeoStem, Inc. DATE OF NAME CHANGE: 20060906 4 1 wf-form4_167347152479762.xml FORM 4 X0306 4 2023-01-09 0 0000320017 LISATA THERAPEUTICS, INC. LSTA 0001309653 AZAB MOHAMMAD C/O LISATA THERAPEUTICS, INC, 110 ALLEN ROAD, 2ND FLOOR BASKING RIDGE NJ 07920 1 0 0 0 Common Stock 2023-01-09 4 A 0 20000 0 A 39200 D Represents 20,000 restricted stock units granted under the Issuer's 2018 Equity Incentive Compensation Plan which will vest on January 9, 2024. Includes 39,200 unvested restricted stock units. James Nisco, Attorney-in-Fact for Mohammad Azab 2023-01-11